Eye Synergy Softgel
Natural health product licensed in Canada
- Other names
- Dr Nutrition Eye Synergy Softgel, Dr Nutrition Opti-Gold, MapleLife Opti-Gold, Maplelife Eye Synergy Softgel, Nutralab Canada Eye Synergy Softgel, Nutralab Opti-Gold, Nutriland Lutein Complex, Opti-Gold, Xanlutin
- Licence holder
- Nutralab Canada Corp.
- NPN or DIN-HM
- 80060086
- Status
- Active licence
- Licence date
- 20 April 2015
- Revision date
- 8 January 2021
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 30 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Zinc: up to 30 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Oxyde de zinc | 30 milligramme | 30,000 µg |
| Huile de poisson Source : Poisson d'huile de poisson - en entier Potency : 10 % Eicosapentaenoic acid | 650 milligramme | Not calculated |
| Huile de poisson Source : Poisson d'huile de poisson - en entier Potency : 50 % Docosahexaenoic acid | Not specified | Not calculated |
| bêta-carotène Source : bêta-carotène | 0.6 milligramme | Not calculated |
| Vitamine E Source : Acétate de d-alpha-tocophéryle | 3.35 mg AT | Not calculated |
| Vitamine E Source : Acétate de d-alpha-tocophéryle | 5 UI | Not calculated |
| Vitamine C Source : Vitamine C | 100 milligramme | 100,000 µg |
| (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol Source : Lutéine(USP) | 4 milligramme | Not calculated |
Non-medicinal ingredients
Rouge FD&C N° 40, Gélatine, Bleu FD&C # 1, Cire d'abeille, Dioxyde de titane, Lécithine, Huile de fève de soja
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of vitamin A to help maintain eyesight, skin, membranes and immune function. Source of vitamin A to help in the development and maintenance of night vision. Helps to maintain eyesight in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to improve macular pigment optical density. Helps to reduce the risk of developing cataracts. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Helps to maintain immune function. An antioxidant for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80060086
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging